Comparison of clinical efficacy and safety of PUVAsol and Unani formulation UNIM-401 (oral) and UNIM-403 (oil) and UVA in the treatment of chronic plaque psoriasis.

Dr. Neena KhannaDeptt. Dermatology and VenereologyAll India Institute of Medical SciencesNew Delhi 1100290 个研究点目标入组 320 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Patients with chronic plaque psoriasis who meet all of the following criteria will be included:
•Age > 18 years
•Psoriasis area severity index (PASI) of >10%
•Body surface involvement (BSA) of >10%

•1.Patients with chronic plaque psoriasis < BSA 10% or PASI <10.
•2.Patients< 18 years of age
•3.Pregnant and lactating mothers
•4.Patients with previous serious adverse effects to photochemotherapy, abnormal photosensitivity or photoaggravated psoriasis.
•5.Patients with renal, hepatic or severe cardiac disease.
•6.Patient with personal or family history of pre-malignant or malignant skin tumors.
•7.Patient unsure about attending treatment schedule regularly and those who do not have a suitable place for sun exposure.
•8.Patients who have received systemic therapy for psoriasis or those who have been treated with immunosuppressive/immunomodulating treatment in previous 8 weeks.
•9.Patients not willing to give consent

发起方

Dr. Neena KhannaDeptt. Dermatology and VenereologyAll India Institute of Medical SciencesNew Delhi 110029